TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT01475617

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: AquaVanta Chewable Tablet
Description: AquaVanta Chewable Tablet (proprietary formulation of vitamin and minerals) 2 times a day for 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Flinstones Complete
Description: Flinstones Complete Multivitamin 2 times a day for 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Nature Made Calcium Softgels
Description: Nature Made Calcium Softgels (Calcium Carbonate 600 mg and Vitamin D 200 mg) three times a day for 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Nature Made Calcium Softgels
Description: Nature Made Calcium Softgels (Calcium Carbonate 600 mg and Vitamin D 200 mg) three times a day for 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Twin Labs Iron Caps
Description: Twin Labs Iron Caps (Ferrous Fumarate) 18 mg per day for menstruating women for 6 months

Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Rexall Vitamin B12 Tablet
Description: Rexall Vitamin B12 Tablet (Cyanocobalamin 500 mcg)per day for 6 months
Study: NCT04437667

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tumaini Mobile Phone Game
Description: Tumaini is a scenario-based role-playing game application. Participants will be instructed to engage in a minimum of 10 hours of gameplay over the holiday period each year. The game will automatically collect for analysis data related to participants' in-game behavior, e.g. time spent playing, scores on knowledge-based mini-games, choices made in the narrative game, components to which the player was exposed. The game is designed to: educate players about sexual health and HIV/AIDS; build risk-reduction skills and related self-efficacy for prevention of HIV/STIs and unintended pregnancy; challenge HIV stigma; and promote parent-child dialogue.

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Control Mobile Phone Game
Description: Independent gameplay of control game. Total respondent burden: participants will be invited to engage in at least 10 hours of gameplay during each long school holiday (November-December).
Study: NCT04011215

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: wool clothing
Description: superfine merino wool ensembles for baby/child wear

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: wool clothing
Description: superfine merino wool ensembles for baby/child wear

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: standard clothing
Description: Standard clothing refers to the clothing normally worn by the infant/child. This will not be superfine merino wool as superfine merino is not generally available for baby wear. The exact nature of the standard clothing will be recorded by investigators. From previous data we expect it to be primarily cotton.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: standard clothing
Description: Standard clothing refers to the clothing normally worn by the infant/child. This will not be superfine merino wool as superfine merino is not generally available for baby wear. The exact nature of the standard clothing will be recorded by investigators. From previous data we expect it to be primarily cotton.
Study: NCT00003439

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: recombinant interleukin-12
Study: NCT03586557

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Corticosteroid & Plasma exchange
Description: High-dose intravenous methylprednisolone 1000mg 3\~5 days and subsequent taper, combined simultaneous plasma exchange 5 times in all

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid
Description: High-dose intravenous methylprednisolone 1000mg 3\~5 days and subsequent taper
Study: NCT02752581

Intervention type: DEVICE
Group type: OTHER
Intervention: Suction drain
Description: A suction drain is used to remove excess fluid from tissues after surgery.

Intervention type: DEVICE
Group type: OTHER
Intervention: No suction drain
Description: A suction drain is used to remove excess fluid from tissues after surgery.
Study: NCT02985528

Intervention type: OTHER
Intervention: further diagnostic
Description: further diagnostic procedures - mainly CHEST CT -

Intervention type: OTHER
Intervention: further diagnostic
Description: further diagnostic procedures - mainly CHEST CT -
Study: NCT00706342

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fostamatinib Disodium / R935788
Description: R935788 tablets
Study: NCT00635999

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Applied relaxation and self-control desensitization
Description: Applied relaxation and self-control desensitization sessions will teach participants relaxation techniques and the use of imagery for coping with anxiety. Treatment will include 14 weekly sessions.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cognitive therapy (CT)
Description: CT sessions will teach participants to identify ways in which they perceive themselves and the world and how to modify these thoughts to reduce anxiety. CT will include 14 weekly sessions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive-Behavioral Therapy
Description: Includes all of the techniques in the other 2 interventions.
Study: NCT04787536

Intervention type: PROCEDURE
Intervention: Non-cardiac surgery
Description: Non-cardiac surgery excluding cranial neurosurgery
Study: NCT00601393

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive behavioral therapy (CBT)
Description: CBT treatment is delivered via the Internet. Adaptations to the CBT program will include the addition of content of particular relevance to mothers of young children and the incorporation of instructional design principles to promote self-learning. The treatment program will take advantage of the unique properties of the Internet, including multimedia presentations and interactive components with professional and moderated peer social support.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive behavioral therapy (CBT)
Description: CBT treatment is delivered via the Internet. Adaptations to the CBT program will include the addition of content of particular relevance to mothers of young children and the incorporation of instructional design principles to promote self-learning. The treatment program will take advantage of the unique properties of the Internet, including multimedia presentations and interactive components with professional and moderated peer social support.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Treatment as usual (TAU)
Description: Participants receiving TAU will be offered the CBT treatment after a wait-list period. During the wait-list period, participants will be offered facilitated referrals to treatment provided in the community.
Study: NCT03924830

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bulk without surface sealant
Description: Adhese SE self-etch adhesive system will be applied according to the manufacturer's instructions in 53 teeth.Then, the Tetric N-Ceram Bulk fill composite will be used in increments of no more than 4 mm, using the bulk restoration technique, and each increment will be photoactivated for 40 seconds.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bulk with Biscover
Description: Adhese SE self-etch adhesive system will be applied according to the manufacturer's instructions in 53 teeth.Then, the Tetric N-Ceram Bulk fill composite will be used in increments of no more than 4 mm, using the bulk restoration technique, and each increment will be photoactivated for 40 seconds. After the restoration is completed, biscover surface sealant will be applied according to the manufacturer's instructions.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bulk with Permaseal
Description: Adhese SE self-etch adhesive system will be applied according to the manufacturer's instructions in 53 teeth.Then, the Tetric N-Ceram Bulk fill composite will be used in increments of no more than 4 mm, using the bulk restoration technique, and each increment will be photoactivated for 40 seconds. After the restoration is completed, Permaseal surface sealant will be applied according to the manufacturer's instructions.
Study: NCT02382380

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gadoterate
Description: Patients who choose to receive Gadoterate will receive an MRI exam with standard pre-contrast and Gadoterate-enhanced acquisitions (0.2 mL/kg). The MRI protocol utilized in the study will be comprised of the standard Body protocols (routine abdomen, liver-pancreas, renal, prostate, angiography) as well as the standard Neurologic exam protocols (routine brain, orbital, brainstem, neck, angiography).

Intervention type: OTHER
Group type: OTHER
Intervention: No Gadoterate
Description: Patients who choose not to receive Gadoterate will receive an MRI exam with no Gadolinium contrast. The MRI protocol utilized in the study will be comprised of the standard Body protocols (routine abdomen, liver-pancreas, renal, prostate, angiography) as well as the standard Neurologic exam protocols (routine brain, orbital, brainstem, neck, angiography).
Study: NCT01280708

Intervention type: OTHER
Intervention: Capture data
Description: Capture and standardization of data of patients aged over 18 years received a kidney transplant or a simultaneous pancreas-kidney transplant from data sources will be performed by clinical research associates.The quality of data will be validated by cross annual audits. The statistical analysis will be made on a case by case according to clinical objectives.
Study: NCT03353506

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: LFMT
Description: Lyophilized fecal microbiota transplant

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: LSFF
Description: Lyophilized sterile fecal filtrate
Study: NCT04743986

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Platelet Rich Plasma (PRP)
Description: RegenLab, Lausanne, Switzerland

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Corticosteroid (CS)
Description: 40mg/ml triamcinolone in 2 ml 0.5% bupivicaine
Study: NCT00930072

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cervical Sympathetic Block (bupivicaine, clonidine)
Description: 12-15ml solution of bupivicaine .5% containing 50 mcg of clonidine for cervical sympathetic block administered in a single injection.
Study: NCT04140513

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Fludeoxyglucose F-18
Description: Given via injection

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo dPET
Study: NCT02640196

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Macintosh
Description: The participants intubated the easy airway simulator with a double lumen tube using the Macintosh laryngoscope followed with intubating the difficult airway simulator

Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: GlideScope
Description: The participants intubated the easy airway simulator with a double lumen tube using the GlideScope followed with intubating the difficult airway simulator

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Airtraq
Description: The participants intubated the easy airway simulator with a double lumen tube using the Airtraq followed with intubating the difficult airway simulator

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: King Vision
Description: The participants intubated the easy airway simulator with a double lumen tube using the King Vision followed with intubating the difficult airway simulator
Study: NCT04464018

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: working grup
Description: After each student received theoretical training, they performed an intravenous injection on the model. In the study group performed hybrid simulation. After finishing the simulation application. the students went to the analysis room and watched their own application videos. The analysis session was held immediately after all the students in the group completed their applications.The IM injection success Test and Student Satisfaction and self-confidence scale were applied to the study and control groups after the laboratory application was completed.
Study: NCT00925925

Intervention type: OTHER
Intervention: Cord blood collection for analysis
Description: Cord blood will be collected from the placentas at delivery for analysis

Intervention type: OTHER
Intervention: Cord blood collection for analysis
Description: Cord blood will be collected from the placentas at delivery for analysis
Study: NCT03290924

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Low dose high frequency health worker training approach
Description: * Two 4-day training sessions for skilled birth attendants~* 1-day peer practice coordinator training after first training session~* Weekly, peer-led practice sessions using MamaNatalie® and NeoNatalie™ anatomic models~* SMS reminder messages and quizzes~* Routine telephone calls between master mentors and peer practice coordinators, and between project staff and master mentors~* Health information officer training~* Data collection and use training~* Supply of simulators, newborn resuscitation equipment, and delivery sets

Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Active Comparison
Description: Training on data collection and reporting
Study: NCT00314795

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Peginesatide
Description: Peginesatide injection
Study: NCT03783715

Intervention type: DRUG
Intervention: Ketoprofen
Description: Ketoprofen 200 mg ER, taken orally, once a day for 6 months. If medication, if obtained from a compound pharmacy, dose will be 210 mg ER, taken orally once a day for 6 months.
Study: NCT04335734

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nissen Fundoplication with wrap fixation
Description: Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization. Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 сm² otherwise mesh for reinforcement of cruroraphy was used. Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures. Wrap was fixated to both diaphragmatic crura or to the body of stomach using two non-absorbable stitches on each side.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Nissen Fundoplication without wrap fixation
Description: Firstly, we performed left crural dissection, division of the short gastric vessels, right crural dissection, and esophageal mobilization. Then repair of HH were made by simple cruroraphy if the size of the defect was less then 10 сm² otherwise mesh for reinforcement of cruroraphy was used. Creation of the wrap was made by passing posterior fundus behind the esophagus from left to right, followed by stitching the edges of the stomach with three interrupted sutures.
Study: NCT01493167

Intervention type: OTHER
Group type: OTHER
Intervention: limb casting/splinting
Description: ankle and arm cast
Study: NCT03351283

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Severe sodium restriction
Description: Patients will be assigned to a diet with sodium restriction of two grams.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Moderate sodium restriction
Description: Patients will be assigned to a diet with sodium restriction of three grams.
Study: NCT01010867

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum strains 299 and 299v
Description: Patients will receive a daily dose of Lactobacillus plantarum: 1 x10\^8 CFU/kg/day. This supplement will be supplied in sachets of powder and will be mixed in water (certain water-based liquid) that is no warmer that 37o C.~Colony forming units (CFU)
Study: NCT04172818

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: quality of life questionnaire
Description: Since 10 years ago, diaries are used in intensive care unit to limit these symptoms after a coma.In analogy, the diary for patients with allogenic hematopoietic stem cell transplantation could be a mean to reduce the psychological adverse impact and long term consequences. The psychological impact of a diary on patients hospitalized for allogenic hematopoetic stem cell transplantation and on their relatives will be evaluated.
Study: NCT02039843

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Emotional Support Dogs
Description: Emotional Support Dogs were required to pass the American Kennel Club Canine Good Citizen and the American Kennel Club Community Canine tests and be well-behaved and well-socialized.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Service Dogs
Description: Service Dogs were required to pass the American Kennel Club Canine Good Citizen and the Assistance Dogs International Public Access tests and trained to complete five PTSD-specific tasks (lights, sweep, bring, block, \& behind).
Study: NCT00884741

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo 3-dimentional conformal radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: 3-Dimensional Conformal Radiation Therapy
Description: Undergo 3-dimentional conformal radiation therapy

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Bevacizumab
Description: Given IV

Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo intensity-modulated radiation therapy

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiation Therapy
Description: Undergo intensity-modulated radiation therapy

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Placebo
Description: Given IV

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Quality-of-Life Assessment
Description: Ancillary studies

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Temozolomide
Description: Given orally

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Given orally
Study: NCT03200080

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tozadenant
Description: 2, 4, 6 or 8 Tozadenant 60 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tozadenant
Description: 2, 4, 6 or 8 Tozadenant 60 mg tablets

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tozadenant
Description: 2, 4, 6 or 8 Tozadenant 60 mg tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: 2, 4, 6 or 8 Tozadenant matching placebo tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo oral tablet
Description: 2, 4, 6 or 8 Tozadenant matching placebo tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Placebo oral tablet
Description: 2, 4, 6 or 8 Tozadenant matching placebo tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: d-amphetamine
Description: 2 or 4 capsules, each containing 2 over-encapsulated d-amphetamine 5 mg tablets

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: d-amphetamine
Description: 2 or 4 capsules, each containing 2 over-encapsulated d-amphetamine 5 mg tablets

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral capsule
Description: 2 or 4 capsules, each containing d-amphetamine matching over-encapsulated PLACEBO 200 mg lactose tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral capsule
Description: 2 or 4 capsules, each containing d-amphetamine matching over-encapsulated PLACEBO 200 mg lactose tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral capsule
Description: 2 or 4 capsules, each containing d-amphetamine matching over-encapsulated PLACEBO 200 mg lactose tablet

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo oral capsule
Description: 2 or 4 capsules, each containing d-amphetamine matching over-encapsulated PLACEBO 200 mg lactose tablet
Study: NCT04521725

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Function Monitor (RFM)
Description: Use of respiratory function monitor to detect tidal volume and expired CO2 to guide mask ventilation during neonatal resuscitation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Respiratory Function Monitor (RFM)
Description: Use of respiratory function monitor to detect tidal volume and expired CO2 to guide mask ventilation during neonatal resuscitation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cerebral Near-Infrared Spectroscopy (NIRS)
Description: Use of cerebral NIRS to determine cerebral oxygenation to guide oxygen titration during neonatal resuscitation.
Study: NCT01017913

Intervention type: OTHER
Group type: NO_INTERVENTION
Intervention: TENS
Description: The TENS equipment was calibrated on 20 hertz frequency, and a pulse width of 330 ms (standing in control number seven) with two channels.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TENS
Description: The TENS equipment was calibrated on 20 hertz frequency, and a pulse width of 330 ms (standing in control number seven) with two channels.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: TENS
Description: The TENS equipment was calibrated on 20 hertz frequency, and a pulse width of 330 ms (standing in control number seven) with two channels.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interferential currents
Description: The IFC was adjusted to a base frequency of 4000 Hz, with a modulation frequency range of 20 Hz, ∆F of 10 Hz and slope of 1/1, in quadripolar mode.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Interferential currents
Description: The IFC was adjusted to a base frequency of 4000 Hz, with a modulation frequency range of 20 Hz, ∆F of 10 Hz and slope of 1/1, in quadripolar mode.
Study: NCT02717806

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: PATHway
Description: Patients will use the PATHway platform for 6 months
Study: NCT01214733

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: tocilizumab [RoActemra/Actemra]
Description: 8 mg/kg intravenously every 4 weeks in combination with allowed DMARDs
Study: NCT04174326

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Immediate intervention group
Description: Participants will be randomized to either the immediate or delayed intervention group at baseline. Participants in both groups will receive CBT for chronic pain management sequentially, once a week during the 6 week intervention period. Participants will be followed-up at 18 weeks from baseline. Two in-between sessions practice assignments will be added to each group therapy session during the the CBT program.